Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2004
03/16/2004US6708158 Method for encoding the volumetric information of a virtual object and the retrieval of same
03/16/2004US6708120 Computer readable memory; analyzing interaction with rotamers; ranking by dead-end elimination (dee) computation
03/16/2004US6708119 Method and apparatus for automatically removing vector unit in DNA base sequence
03/16/2004US6706954 Yellow, dent maize inbred suited as male for producing first generation f1 maize hybrids; homozygous, can be reproduced by planting seeds, growing plants under self-pollinating or sib-pollinating conditions with adequate isolation
03/16/2004US6706952 Arabidopsis gene encoding a protein involved in the regulation of SAR gene expression in plants
03/16/2004US6706951 Isolated nucleotide sequence encoding specified amino acid sequence; regulating levels of gdp-mannose, substrate for formation of gum galactomannan
03/16/2004US6706950 Nucleotide sequences coding enzymatic polypeptide for use in generating plants with reduced saturated fatty acid concentration; herbicide resistance; freeze resistance
03/16/2004US6706949 Isolated polynucleotide comprising specified nucleic acid sequence which encodes polypeptide with ruvb activity or nucleic acid sequence which is fully complementary; homologous recombination
03/16/2004US6706948 Purified nucleic acid sequence; promoter sequence capable of driving transgene expression in both monocotyledonous and dicotyledonous plant cells; generating transgenic plants
03/16/2004US6706922 Process of making a compound by forming a polymer from a template drug
03/16/2004US6706874 Viral nucleotide sequences for use in the prevention and treatment of viral diseases
03/16/2004US6706873 Nucleic acid molecule encoding specified amino acid sequence
03/16/2004US6706871 Isolated polynucleotide comprising specified nucleotide sequence which encodes polypeptide having specified amino acid sequence
03/16/2004US6706870 Nucleic acids encoding CTLA-8; and related reagents
03/16/2004US6706866 Plant having altered environmental stress tolerance
03/16/2004US6706860 Toxins
03/16/2004US6706858 Use of alkanes for contamination-free purification or separation of biopolymers
03/16/2004US6706762 Methods for the use of inhibitors of co-repressors for the treatment of neoplastic diseases
03/16/2004US6706694 Expression of exogenous polynucleotide sequences in a vertebrate
03/16/2004US6706693 Vaccination by topical application of genetic vectors
03/16/2004US6706687 Platelet-derived growth factor D
03/16/2004US6706683 Method for controlling the release of granules
03/16/2004US6706682 Increasing or maintaining the blood supply in the penis
03/16/2004US6706525 Highly transformable bacterial cells and methods for producing the same
03/16/2004US6706524 Method of improving the primary energy metabolism of mammalian cell lines
03/16/2004US6706523 Nucleoprotein is mutated at the amino acid wherein phosphorylation occurs
03/16/2004US6706516 Engineering of metabolic control
03/16/2004US6706515 EHV-1 vectors
03/16/2004US6706514 Polypeptides capable of interacting with the human topoisomerase IIIα
03/16/2004US6706513 Autoimmune disease; sexual disorders
03/16/2004US6706509 Serine and threonine kinase activity
03/16/2004US6706508 Isolated polypeptide comprising specified amino acid sequence, which exhibits ornithine carbamoyltransferase activity
03/16/2004US6706507 (R)-2-octanol dehydrogenases, methods for producing the enzymes, DNA encoding the enzymes, and methods for producing alcohols using the enzymes
03/16/2004US6706503 Generating preferential microorganisms; obtain microorganism containing mutant gene, express gene and evaluate microorganism mutation response
03/16/2004US6706501 Isolated nucleic acid molecule comprising selected nucleic acid sequence, encoding protein having 10,12-linoleate isomerase activity
03/16/2004US6706499 Amplification preferential nucleotide sequences in sample; obtain sample nucleotide sequences, store in preservation fluid, drain fluid, recover nucleotide sequence amplify sequences, evaluate nucleotide sequences
03/16/2004US6706498 Method for isolating DNA
03/16/2004US6706497 Methods for producing sialyloligosaccharides in a dairy source
03/16/2004US6706496 Method for expression of heterologous proteins in yeast
03/16/2004US6706495 Staphylococcal GTPase obg nucleotide sequence encoding Staphylococcal GTP-binding protein
03/16/2004US6706494 Isolated recombinant polypeptide comprising specified amino acid sequence or immunogenic fragment comprising at least 15 contiguous amino acids, which induces antibody- or t-cell mediated immune response that recognizes polypeptide
03/16/2004US6706493 Nucleotide sequences coding polypeptide for use in the treatment of schizophrenia, parkinson's, drug addiction and eating disorders
03/16/2004US6706491 Reagents and methods for identifying and modulating expression of genes regulated by p21
03/16/2004US6706488 Antigenic compound for use in the treatment,and diagnosis of cancer
03/16/2004US6706484 Protein/(poly)peptide libraries
03/16/2004US6706482 Conditional-selex
03/16/2004US6706481 In vitro selection of signaling aptamers
03/16/2004US6706479 Bio-chip, photoluminescent methods for identifying biological material, and apparatuses for use with such methods and bio-chips
03/16/2004US6706478 Diagnosis of preferential genetic disorders; obtain cell, incubate with probe, detect signal, presence of signal indicates genetic disorders
03/16/2004US6706477 Cell differentiation; antitumor, anticancer agents
03/16/2004US6706476 Annealing cdna synthesis primer to rna molecule, synthesizing first cdna strand to form rna-cdna intermediate, separating cdna strand, purifying, ligating with adaptor consisting of two hybridized oligonucleotides, amplifying product
03/16/2004US6706472 Group of nucleic acid molecules salmonella detection, nucleic acids, kit and use
03/16/2004US6706470 Gene switches
03/16/2004US6706394 Method and apparatus for manufacture of magnetizable microparticles
03/16/2004US6706271 Cloning of BASB023 antigen from Moraxella catarrhalis
03/16/2004US6706270 Compounds
03/16/2004US6706265 Immunosuppressing graft rejection
03/16/2004US6706261 Compositions and methods comprising immunogenic muteins of interleukin-6
03/16/2004CA2311239C Methods for defining cell types
03/16/2004CA2262500C Measles virus mutant antigen and gene coding for the same
03/16/2004CA2136961C Bnp antibody and immunoassay using it
03/16/2004CA2122837C Method for refolding igf-1 to active conformation
03/11/2004WO2005027710A2 Methods for identifying subjects at risk of melanoma and treatments thereof
03/11/2004WO2004021010A2 Method of diagnosing colon and gastric cancers
03/11/2004WO2004020999A1 Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer
03/11/2004WO2004020733A1 Apparatus and method for automatically defibering and extracting kraft pulp from old corrugated cardboard
03/11/2004WO2004020673A1 Compositions of solution for sequencing reaction clean-up
03/11/2004WO2004020672A1 Targets for type i and type ii diabetes
03/11/2004WO2004020671A1 Primer and probe for detecting vibrio vulnificus and detection method using the same
03/11/2004WO2004020667A1 Novel integrated microarray analysis
03/11/2004WO2004020665A2 Diagnostic and therapeutic use of foap-13 polynucleotides and polypeptides for neurodegenerative diseases
03/11/2004WO2004020654A2 Solid phase based nucleic acid assays combining high affinity and high specificity
03/11/2004WO2004020645A2 Chromosomal loci for the stringent control of gene activities via transcription activation systems
03/11/2004WO2004020644A1 Non-human herpesviruses as vectors
03/11/2004WO2004020643A2 Regulated bacterial lysis for gene vaccine vector delivery and antigen release
03/11/2004WO2004020642A2 Stress tolerance and delayed senescence in plants
03/11/2004WO2004020641A1 Plant gene engineering manipulation method with biological safety
03/11/2004WO2004020640A2 Zinc-regulated prokaryotic expression cassettes
03/11/2004WO2004020639A2 Production of multimeric fusion proteins using a c4bp scaffold
03/11/2004WO2004020638A1 Process for producing glucose dehydrogenases
03/11/2004WO2004020637A1 Flavonoid 3',5'hydroxylase gene sequences and uses therefor
03/11/2004WO2004020636A1 Nucleotide sequences encoding cry1bb proteins for enhanced expression in plants
03/11/2004WO2004020635A1 Bacteriophages and remedies for bacterial infection
03/11/2004WO2004020634A1 Mutant forms of meningococcal adp-ribosylating toxin
03/11/2004WO2004020633A1 Human antihuman interleukin-6 antibody and fragment of the antibody
03/11/2004WO2004020632A1 Method for the detection of genes specifying allergen
03/11/2004WO2004020631A2 Genetic suppression and replacement
03/11/2004WO2004020630A2 Method for gene isolation by cre-trap cloning
03/11/2004WO2004020629A1 Recovery of plasmids in an aqueous two-phase system
03/11/2004WO2004020628A1 Method for genetically engineering plant-derived nucleic acid sequences comprising gene shuffling and selective mutagenesis
03/11/2004WO2004020627A2 Improved dna and proteins
03/11/2004WO2004020625A1 SELECTION AND ISOLATION OF LIVING CELLS USING mRNA-BINDING PROBES
03/11/2004WO2004020623A2 Method for producing biodegradable, functionalised polymer particles, and use of the same as medicament carriers
03/11/2004WO2004020621A1 Thermostable ribonuclease h
03/11/2004WO2004020612A1 Methods for producing mammalian trypsins
03/11/2004WO2004020605A2 Circular nucleic acid vectors, and methods for making and using the same
03/11/2004WO2004020604A2 Allele specific primer extension
03/11/2004WO2004020603A2 Analyte detection
03/11/2004WO2004020602A2 Terminal phosphate blocked nucleoside polyphosphates
03/11/2004WO2004020600A2 Modified aav